CTCL In-Person Patient and Carer Education Day


We are excited to invite you to our upcoming In-Person Education Day in Melbourne for patients and carers of those diagnosed with Cutaneous T-Cell Lymphoma.

This FREE event is a wonderful opportunity to:

– Learn more about the management, treatment and supportive care of skin lymphomas
– Hear from expert speakers in the field
– Enjoy a complimentary lunch
– Connect with others who are on a similar journey

We look forward to welcoming you for an informative and supportive day. For more information please email nurse@lymphoma.org.au or call our Nurse Support Line on 1800 953 081.

Registrations are essential as places are limited.

Agenda

09:30am

Registration and Coffee

10:00am

Session One: UV Therapy, Psychology and Quality of Life, Haematology Side of Cutaneous Lymphoma and Panel Discussions

12:00pm

Lunch

12:40pm

Session Two: Skin Directed Chemotherapy, Radiation Oncology, Systemic Treatments for Cutaneous T-cell Lymphoma, Carers Victoria, Skincare Symptom Management and Panel Discussions

2:30pm

Wrap Up and Close

There is limited availability for this event, so secure your spot quickly.
This event has already taken place.
Details
Date: Friday 11th of September 2026
Time: 9:30am AEST - 2:30pm AEST
Location: Level 7 Lecture Theatre, Peter MacCallum Cancer Centre
305 Grattan Street, Melbourne VIC 3000

Support and information

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.